EDGAR Filing Documents for 0001509190-17-000041

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001509190-17-000041

Filing Date

2017-08-04

Accepted

2017-08-04 08:11:45

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3	petx-20170804xs3.htm	S-3	445702
2	EX-4.5	petx-20170804xex4_5.htm	EX-4.5	616544
3	EX-5.1	petx-20170804xex5_1.htm	EX-5.1	64246
4	EX-12.1	petx-20170804xex12_1.htm	EX-12.1	96508
5	EX-23.2	petx-20170804xex23_2.htm	EX-23.2	2881
6	EX-25.1	petx-20170804xex25_1.htm	EX-25.1	223724
7	GRAPHIC	petx-20170804xex5_1g001.jpg	GRAPHIC	2012
8	GRAPHIC	petx-20170804xex5_1g002.jpg	GRAPHIC	8689
9	GRAPHIC	petx-20170804xs3g001.jpg	GRAPHIC	17959
	Complete submission text file	0001509190-17-000041.txt		1490539

Mailing Address 11400 TOMAHAWK CREEK PARKWAY, SUITE 340 LEAWOOD KS 66211

Business Address 11400 TOMAHAWK CREEK PARKWAY, SUITE 340 LEAWOOD KS 66211 913.353.1000

ARATANA THERAPEUTICS, INC. (Filer) CIK: 0001509190 (see all company filings)